John Devane

John Devane

Director/Board Member at Saol Holdings LLC

Health Technology
Finance
Consumer Services

Profile

John Devane is the founder of AGI Therapeutics Plc (founded in 2003) and Athpharma Ltd.
(founded in 2001).
He held the title of Chief Executive Officer & Executive Director at AGI Therapeutics Plc and Chief Executive Officer at Athpharma Ltd.
Dr. Devane's current jobs include Director positions at Sebela Pharmaceuticals, Inc., Saol Therapeutics Research Ltd., Saol Holdings LLC, and Senior Advisor at Avego Healthcare Capital LLC.
Dr. Devane's former jobs include Non-Executive Director at Dignity Sciences Ltd., Executive Vice President-Research & Development at Elan Corp.
Plc, Chief Scientific Officer & Senior Vice President at Horizon Therapeutics Plc, Chief Scientific Officer at HZNP USA LLC, and Advisor at Amplitude Healthcare Acquisition Corp.
Dr. Devane received a doctorate degree from University College Dublin in 1982 and an undergraduate degree from the same institution in 1978.

John Devane active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member -
Director/Board Member -
Consultant / Advisor -
All active positions of John Devane

Former positions of John Devane

CompaniesPositionEnd
Founder 2011-12-31
Athpharma Ltd. Founder 2004-12-31
Chief Tech/Sci/R&D Officer 2000-12-31
AMPLITUDE HEALTHCARE ACQUISITION CORPORATION Corporate Officer/Principal -
Director/Board Member -
See the detail of John Devane's experience

Training of John Devane

University College Dublin Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Devane's experience

Connections

100 +

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Athpharma Ltd.

Commercial Services

Health Technology

Health Technology

Distribution Services

Finance

Health Technology

Finance

Finance

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW